News Conference News ACC 2022 In Vaccine Era, Deaths Drop Sharply in STEMI Patients With COVID-19 Caitlin E. Cox April 04, 2022
News Conference News ACC 2022 Seasonal, but No Year-round Help for HF With Flu Shots: IVVE Yael L. Maxwell April 03, 2022
News Conference News ACC 2022 SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization L.A. McKeown April 02, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Conference News ACC 2022 Can a Smartphone App Use Voice Patterns to Predict CAD Events? Caitlin E. Cox March 24, 2022
News Conference News ISC 2022 Ischemic Stroke Risk Highest Early After COVID-19 Diagnosis Todd Neale February 17, 2022
News Conference News ISC 2022 Endovascular Stroke Therapy Works for Large Infarcts: RESCUE-Japan LIMIT Todd Neale February 09, 2022
News Conference News THT 2022 Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality Caitlin E. Cox February 07, 2022
News Conference News STS 2022 CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices Todd Neale February 03, 2022
News Conference News STS 2022 Modified Surgical MV Repair Stands Up to Replacement Michael O'Riordan February 03, 2022
News Conference News THT 2022 PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients L.A. McKeown February 03, 2022
News Conference News PCR London Valves 2021 MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND Shelley Wood November 26, 2021
News Conference News PCR London Valves 2021 ‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI Michael O'Riordan November 25, 2021
News Conference News PCR London Valves 2021 Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry Shelley Wood November 24, 2021
News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021
News Conference News Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward Todd Neale November 16, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AHA 2021 Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE Shelley Wood November 14, 2021
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021